|
Corgenix Medical Corporation is
based in metropolitan Denver, with its international marketing office near
Cambridge, England. Corgenix is focused on the development and promotion of
specialized diagnostic test kits for vascular diseases and immunological
disorders. Corgenix diagnostic products are commercialized for use in clinical
laboratories worldwide.
Statements that are not
strictly historical are “forward- looking” statements within the meaning of
the Private Securities Litigation Reform Act of 1995, and should be considered
as subject to various risks and uncertainties that could cause actual results to
differ materially from those anticipated. Further risks are detailed in the
Company's filings with the Securities and Exchange Commission, including those
set forth in the Company's most recent Form 10-KSB and Quarterly Reports on Form
10-QSB.
[ Press Room ] [ Stock Chart ] [ Request Investment Info. ] [ Audit Committee Charter ] [ Compensation Committee Charter ] [ Nominating Committee Charter ] [ Corporate Code of Ethics ]
|
